Maria Vargas

Convergent Antibody Signatures in Human Dengue

Poornima Parameswaran, Yi Liu, Krishna M. Roskin et al. · Cell Host & Microbe · 2013 · 280 citations · Full text

Convergent Antibody Signatures, Immunology, Virology +4

Symptomatic Versus Inapparent Outcome in Repeat Dengue Virus Infections Is Influenced by the Time Interval between Infections and Study Year

Magelda Montoya, Lionel Gresh, Juan Carlos Mercado et al. · PLoS neglected tropical diseases · 2013 · 254 citations · Full text

Vector-borne Pathogen, Infectious Disease Epidemiology, Virus Epidemiology +13

Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever

Anna P. Durbin, Maria Vargas, Kimberli Wanionek et al. · Virology · 2008 · 232 citations · Full text

Increased Activation, Humoral Response, Hematology +8

Safety and immunogenicity of a tetravalent dengue vaccine in children aged 2–17 years: a randomised, placebo-controlled, phase 2 trial

Vianney Tricou, Xavier Sáez‐Llorens, Delia Yu et al. · The Lancet · 2020 · 103 citations

Vaccination, Vaccine Safety, Vaccinology +6

Immunogenicity and safety of one versus two doses of tetravalent dengue vaccine in healthy children aged 2–17 years in Asia and Latin America: 18-month interim data from a phase 2, randomised, placebo-controlled study

Xavier Sáez‐Llorens, Vianney Tricou, Delia Yu et al. · The Lancet Infectious Diseases · 2017 · 74 citations

Vaccination, Vaccine Safety, Vaccinology +12